Artivion (AORT) Competitors $30.59 +0.30 (+0.99%) Closing price 07/8/2025 03:59 PM EasternExtended Trading$30.60 +0.00 (+0.02%) As of 07/8/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AORT vs. IRTC, NARI, TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, and WRBYShould you be buying Artivion stock or one of its competitors? The main competitors of Artivion include iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Artivion vs. Its Competitors iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker iRhythm Technologies (NASDAQ:IRTC) and Artivion (NYSE:AORT) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation. Which has more risk & volatility, IRTC or AORT? iRhythm Technologies has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Artivion has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Is IRTC or AORT more profitable? Artivion has a net margin of -5.49% compared to iRhythm Technologies' net margin of -15.90%. Artivion's return on equity of 3.63% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-15.90% -101.04% -9.55% Artivion -5.49%3.63%1.34% Which has stronger valuation & earnings, IRTC or AORT? Artivion has lower revenue, but higher earnings than iRhythm Technologies. Artivion is trading at a lower price-to-earnings ratio than iRhythm Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$591.84M7.26-$113.29M-$3.14-42.88Artivion$388.54M3.36-$13.36M-$0.50-61.18 Does the media refer more to IRTC or AORT? In the previous week, iRhythm Technologies had 10 more articles in the media than Artivion. MarketBeat recorded 11 mentions for iRhythm Technologies and 1 mentions for Artivion. Artivion's average media sentiment score of 1.70 beat iRhythm Technologies' score of 0.65 indicating that Artivion is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Artivion 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts prefer IRTC or AORT? iRhythm Technologies presently has a consensus target price of $138.60, indicating a potential upside of 2.95%. Artivion has a consensus target price of $32.40, indicating a potential upside of 5.92%. Given Artivion's stronger consensus rating and higher possible upside, analysts plainly believe Artivion is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Do insiders & institutionals believe in IRTC or AORT? 86.4% of Artivion shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by insiders. Comparatively, 8.1% of Artivion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryArtivion beats iRhythm Technologies on 12 of the 17 factors compared between the two stocks. Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AORT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AORT vs. The Competition Export to ExcelMetricArtivionMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$1.29B$6.74B$5.47B$20.52BDividend YieldN/A1.29%5.25%3.76%P/E Ratio-61.1824.9227.0027.79Price / Sales3.3687.45435.7540.48Price / Cash36.3120.5836.8222.26Price / Book4.644.727.984.58Net Income-$13.36M$173.18M$3.16B$982.91M7 Day Performance-0.96%1.14%2.40%0.41%1 Month Performance4.76%-0.17%2.19%3.59%1 Year Performance18.29%21.18%33.82%14.47% Artivion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AORTArtivion2.7704 of 5 stars$30.59+1.0%$32.40+5.9%+19.3%$1.29B$388.54M-61.181,600IRTCiRhythm Technologies1.0367 of 5 stars$153.96-0.5%$138.60-10.0%+40.4%$4.94B$591.84M-49.032,000News CoverageNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.5222 of 5 stars$134.01+1.9%$127.33-5.0%-16.4%$4.45B$441.54M98.54210BLCOBausch + Lomb3.1036 of 5 stars$13.03+5.1%$15.54+19.3%-8.2%$4.39B$4.79B25.8313,500Analyst ForecastHigh Trading VolumeSLNOSoleno Therapeutics4.7235 of 5 stars$83.78+0.6%$107.10+27.8%+101.0%$4.20BN/A-18.1330INSPInspire Medical Systems4.8272 of 5 stars$129.28-2.4%$211.91+63.9%-1.7%$3.91B$802.80M59.581,246News CoveragePositive NewsNVSTEnvista3.8065 of 5 stars$19.58-0.5%$20.23+3.3%+22.8%$3.33B$2.51B-3.0012,300PRCTPROCEPT BioRobotics2.6605 of 5 stars$57.60+1.2%$90.00+56.3%-9.8%$3.15B$224.50M-33.88430News CoverageAnalyst ForecastLIVNLivaNova3.2024 of 5 stars$45.02-1.6%$59.29+31.7%-9.6%$2.49B$1.25B-11.012,900Positive NewsWRBYWarby Parker1.9504 of 5 stars$21.94+0.2%$22.88+4.3%+45.0%$2.29B$771.32M0.003,780 Related Companies and Tools Related Companies iRhythm Technologies Competitors Inari Medical Competitors TransMedics Group Competitors Bausch + Lomb Competitors Soleno Therapeutics Competitors Inspire Medical Systems Competitors Envista Competitors PROCEPT BioRobotics Competitors LivaNova Competitors Warby Parker Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AORT) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artivion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AORT Stock Alerts